Instil Bio, Inc.

NASDAQ (USD): Instil Bio, Inc. (TIL)

Last Price

20.61

Today's Change

+0.53 (2.63%)

Day's Change

19.12 - 21.90

Trading Volume

63,056

Overview

Market Cap

134 Million

Shares Outstanding

6 Million

Avg Volume

143,688

Avg Price (50 Days)

29.47

Avg Price (200 Days)

20.92

PE Ratio

-1.78

EPS

-11.56

Earnings Announcement

19-Mar-2025

Previous Close

20.08

Open

19.97

Day's Range

19.12 - 21.9

Year Range

6.88 - 92.0

Trading Volume

62,678

Price Change Highlight

1 Day Change

2.64%

5 Day Change

-6.36%

1 Month Change

-16.76%

3 Month Change

-68.89%

6 Month Change

99.52%

Ytd Change

165.25%

1 Year Change

201.32%

3 Year Change

-93.30%

5 Year Change

-96.10%

10 Year Change

-96.10%

Max Change

-96.10%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 to recognize folate receptor alpha (FOLR1) with indications, including gynecological, non-small cell lung cancer, renal caner, and others. The company was incorporated in 2018 and is headquartered in Dallas, Texas.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment